Skip to main content
Find a Lawyer

all - Opinion Summaries

FILL IN AT LEAST ONE FIELD

Format is YYYYMMDD

Page 7 of 88 Showing Result 61 - 70 of 874
Description Date Docket #

Novartis AG . v. Torrent Pharms. Ltd.

United States Federal Circuit
Intellectual Property, Patent, Drugs & Biotech
In an appeal from the Final Written Decision of the United States Patent and Trademark Office, Patent Trial and Appeal Board in two consolidated inter...
04/12/2017 2016-1352

The Medecines Co. v. Mylan, Inc.

United States Federal Circuit
Intellectual Property, Patent, Drugs & Biotech
In a suit filed in response to an Abbreviated New Drug Application (ANDA) submitted by defendant, involving patents directed to pharmaceutical...
04/06/2017 2015-1113, 2015-1151, 2015-1181

Novartis AG v. Noven Pharms., Inc.

United States Federal Circuit
Intellectual Property, Patent, Drugs & Biotech
In an appeal of inter partes review of pharmaceutical patents, the Patent Trial and Appeal Board's findings that various claims of the Patents-in-Suit...
04/04/2017 2016-1678, 2016-1679

In Re: Fosamax Products Liability Litig.

United States Third Circuit
Health Law, Injury & Tort Law, Drugs & Biotech, Product Liability
In consolidated personal-injury suits against a drug manufacturer, averring that the osteoporosis drug Fosamax caused plaintiffs to suffer serious...
03/22/2017 14-1900

McClain v. Sav-On Drugs

California Court of Appeal
Tax Law, Drugs & Biotech
In a class action suit filed by a group of customers predicated on their ability to obtain an order compelling the retail pharmacies to file an...
03/13/2017 B265011

Life Technologies Corp. v. Promega Corp.

United States Supreme Court
Intellectual Property, Patent, Drugs & Biotech
In an infringement suit in which plaintiff sublicensed a patent, which claims a toolkit for genetic testing, for the manufacture and sale of the kits...
02/22/2017 14-1538

Shire Development, LLC v. Watson Pharms., Inc.

United States Federal Circuit
Intellectual Property, Patent, Drugs & Biotech
In a suit alleging defendant's infringement by filing an Abbreviated New Drug Application (ANDA) with the Food and Drug Administration seeking to...
02/10/2017 2016-1785

Booker v. Pfizer, Inc.

United States First Circuit
Health Law, Injury & Tort Law, Drugs & Biotech
In a qui tam action against a pharmaceutical defendant in federal district court, on behalf of the U.S., more than two dozen individual states, and...
01/30/2017 16-1805

Cumberland Pharms. Inc. v. Mylan Institutional LLC

United States Federal Circuit
Intellectual Property, Patent, Drugs & Biotech
In an infringement involving a patent which describes and claims acetylcysteine compositions substantially free of chelating agents, the district...
01/26/2017 2016-1155, 2016-1259

Eli Lily and Co. v. Teva Parenteral Medicines, Inc.

United States Federal Circuit
Intellectual Property, Patent, Drugs & Biotech
In a consolidated Hatch-Waxman suit to prevent Defendants from launching a generic version of a chemotherapy drug with accompanying product literature...
01/12/2017 2015-2067

Results 61 to 70 of 874

Copied to clipboard